These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 25547352

  • 1. Effects of tigecycline and vancomycin administration on established Clostridium difficile infection.
    Theriot CM, Schumacher CA, Bassis CM, Seekatz AM, Young VB.
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1596-604. PubMed ID: 25547352
    [Abstract] [Full Text] [Related]

  • 2. Tigecycline for the treatment of severe Clostridium difficile infection.
    Larson KC, Belliveau PP, Spooner LM.
    Ann Pharmacother; 2011 Jul; 45(7-8):1005-10. PubMed ID: 21730279
    [Abstract] [Full Text] [Related]

  • 3. The role of tigecycline in the management of Clostridium difficile infection: a retrospective cohort study.
    Manea E, Sojo-Dorado J, Jipa RE, Benea SN, Rodríguez-Baño J, Hristea A.
    Clin Microbiol Infect; 2018 Feb; 24(2):180-184. PubMed ID: 28642147
    [Abstract] [Full Text] [Related]

  • 4. Tigecycline exhibits inhibitory activity against Clostridium difficile in the colon of mice and does not promote growth or toxin production.
    Jump RL, Li Y, Pultz MJ, Kypriotakis G, Donskey CJ.
    Antimicrob Agents Chemother; 2011 Feb; 55(2):546-9. PubMed ID: 21135181
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection.
    Freeman J, Baines SD, Jabes D, Wilcox MH.
    J Antimicrob Chemother; 2005 Oct; 56(4):717-25. PubMed ID: 16143709
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model.
    Baines SD, Saxton K, Freeman J, Wilcox MH.
    J Antimicrob Chemother; 2006 Nov; 58(5):1062-5. PubMed ID: 17030519
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evidence for low risk of Clostridium difficile infection associated with tigecycline.
    Wilcox MH.
    Clin Microbiol Infect; 2007 Oct; 13(10):949-52. PubMed ID: 17697004
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of Clostridium difficile infection using SQ641, a capuramycin analogue, increases post-treatment survival and improves clinical measures of disease in a murine model.
    Moore JH, van Opstal E, Kolling GL, Shin JH, Bogatcheva E, Nikonenko B, Einck L, Phipps AJ, Guerrant RL, Protopopova M, Warren CA.
    J Antimicrob Chemother; 2016 May; 71(5):1300-6. PubMed ID: 26832756
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A new strategy for the prevention of Clostridium difficile infection.
    Howerton A, Patra M, Abel-Santos E.
    J Infect Dis; 2013 May 15; 207(10):1498-504. PubMed ID: 23420906
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The outcome of patients with severe and severe-complicated Clostridium difficile infection treated with tigecycline combination therapy: a retrospective observational study.
    Bishop EJ, Tiruvoipati R, Metcalfe J, Marshall C, Botha J, Kelley PG.
    Intern Med J; 2018 Jun 15; 48(6):651-660. PubMed ID: 29363242
    [Abstract] [Full Text] [Related]

  • 19. Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice.
    Ajami NJ, Cope JL, Wong MC, Petrosino JF, Chesnel L.
    Antimicrob Agents Chemother; 2018 May 15; 62(5):. PubMed ID: 29463537
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model.
    Ochsner UA, Bell SJ, O'Leary AL, Hoang T, Stone KC, Young CL, Critchley IA, Janjic N.
    J Antimicrob Chemother; 2009 May 15; 63(5):964-71. PubMed ID: 19251726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.